Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$618.46 USD

618.46
1,324,097

-5.75 (-0.92%)

Updated Sep 11, 2024 04:00 PM ET

After-Market: $618.47 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Thermo Fisher (TMO) Invites Applications for Oncomine Program

by Zacks Equity Research

Thermo Fisher (TMO) to review research proposals eligible for the Oncomine Clinical Research Grant program.

Thermo Fisher's (TMO) New Launch Boosts Preclinical Development

by Zacks Equity Research

Thermo Fisher's (TMO) enhanced Quick to Clinic solution provides balance of speed and quality to accelerate and advance DNA to Investigational New Drug in as less as 13 months.

Thermo Fisher (TMO) End Markets Rebound as COVID-19 Cases Drop

by Zacks Equity Research

In academic and government end markets, Thermo Fisher (TMO) grows on robust customer activity globally.

Kaustav Ghosh headshot

4 Stocks to Watch in the Growing Nanotechnology Market

by Kaustav Ghosh

Watch out for names like Onto Innovation (ONTO), DuPont de Nemours (DD), Thermo Fisher Scientific (TMO) and International Business Machines (IBM) as the nanotechnology market continues to grow.

The Zacks Analyst Blog Highlights: JPMorgan, PayPal, Thermo Fisher Scientific, PepsiCo, McDonald's and Canadian National Railway

by Zacks Equity Research

The Zacks Analyst Blog Highlights: JPMorgan, PayPal, Thermo Fisher Scientific, PepsiCo, McDonald's and Canadian National Railway

Sheraz Mian headshot

Top Analyst Reports for JPMorgan, PayPal & Thermo Fisher

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), PayPal (PYPL), and Thermo Fisher Scientific (TMO).

Riya Anand headshot

3 Medical Diagnostics Stocks in Focus on Long-Term Potential

by Riya Anand

MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed at $445.33 in the latest trading session, marking a -0.86% move from the prior day.

Moderna (MRNA) Files for Full Approval of COVID-19 Vaccine

by Zacks Equity Research

Moderna (MRNA) seeks full approval for its COVID-19 vaccine, mRNA-1273, in adults with initiation of rolling submission of a BLA. The company also boosts manufacturing capacity for the vaccine.

LabCorp (LH) New Study Looks at COVID-19 Antibody Longevity

by Zacks Equity Research

LabCorp (LH) claims this to be the largest known COVID-related study in terms of specimen volume.

Thermo Fisher's (TMO) New Alliance Boosts Electron Microscopy

by Zacks Equity Research

This instrument by Thermo Fisher (TMO) is set to play a vital role in developing advanced solar cells, transport alloys, battery materials, low-energy electronics, catalysts and biodegradable polymers.

Thermo Fisher (TMO) to Boost Cell Therapies With UCSF Deal

by Zacks Equity Research

Thermo Fisher's (TMO) collaboration with UCSF will enable end-to-end solution to accelerate cell therapy development and manufacturing with new facility.

The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev

by Zacks Equity Research

The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev

Sheraz Mian headshot

Top Stock Reports for UnitedHealth, PayPal & NextEra

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), PayPal (PYPL), and NextEra (NEE).

Sweta Killa headshot

Healthcare ETFs on Radar As Q1 Earnings Unfold

by Sweta Killa

Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate returns.

Trina Mukherjee headshot

Medical Products' Apr 29 Earnings Roster: TMO, BAX & More

by Trina Mukherjee

The Medical Product companies' first-quarter results are likely to reflect robust earnings and revenue growth on solid base business recovery.

Is a Surprise Coming for Thermo Fisher (TMO) This Earnings Season?

by Zacks Equity Research

Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PerkinElmer (PKI) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

PerkinElmer's (PKI) first-quarter results are likely to reflect strong performance at Diagnostics segment.

Thermo Fisher (TMO) to Report Q1 Earnings: WIll It Beat?

by Zacks Equity Research

Fewer hospital visits on growing new cases might have once again impacted the level of routine diagnostics testing activity for Thermo Fisher (TMO) in Q1.

Baxter (BAX) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Baxter's (BAX) first-quarter results are likely to reflect growth in its Acute Therapies business.

DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

DexCom's (DXCM) first-quarter results are likely to reflect rising global awareness of its real-time CGM.

Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stryker (SYK) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Stryker's (SYK) first-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Thermo Fisher (TMO) to Expand in Pharma Service With PPD Buyout

by Zacks Equity Research

Thermo Fisher's (TMO) $17.4-billion acquisition deal will offer the company meaningful cost and revenue synergies.